Recombinant T-cell receptor ligand RTL1000 limits inflammation and decreases infarct size after experimental ischemic stroke in middle-aged mice

W. Zhu, A. L. Dotson, N. L. Libal, A. S. Lapato, S. Bodhankar, H. Offner, N. J. Alkayed

Research output: Contribution to journal › Article › peer-review

16 Scopus citations

Fingerprint

Dive into the research topics of 'Recombinant T-cell receptor ligand RTL1000 limits inflammation and decreases infarct size after experimental ischemic stroke in middle-aged mice'. Together they form a unique fingerprint.

Medicine & Life Sciences